Glycan-based strategies for drug development fall into two main categories: restorative therapies and interventions. Restorative therapies seek to replace biomolecules that the body fails to synthesize adequately. Drugs that can intervene in glycan-dependent disease processes represent a novel niche for drug discovery research, where the manipulation of molecular interactions holds the promise of improving patient outcomes.